ARROW-PERINDOPRIL 2 perindopril erbumine 2mg tablets blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

perindopril erbumine, Quantity: 2 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Perindopril erbumine

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate

Administration route:

Oral

Units in package:

30 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Treatment of hypertension. Treatment of heart failure. In such patients, it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision (the safety and efficacy of perindopril have not been demonstrated for New York Heart Association category IV patients). Patients with established coronary artery disease (see Clinical Trials), who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Product summary:

Visual Identification: White to off-white, round convex tablet, embossed with "P2" on one side and ">" (Arrow logo) on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2007-10-03